SCHEMBL8172035

SCHEMBL8172035

Nc1cccc(C=CC=C2SC(=S)NC2=O)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKR1B1 P15121 1/20 0.52
▸ NAT1 P18440 3/20 0.50
▸ CISD1 Q9NZ45 2/20 0.50
▸ CA2 P00918 1/20 0.50
▸ EPHX1 P07099 1/20 0.50
▸ RAB9A P51151 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ HSP90AA1 P07900 1/20 0.46
▸ THRB P10828 1/20 0.46
▸ TNNI3 P19429 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ TNNT2 P45379 1/20 0.46
▸ RECQL P46063 1/20 0.46
▸ TNNC1 P63316 1/20 0.46
▸ MCL1 Q07820 1/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8181146 0.79 PIM1 (0.71) NAT1CA2EPHX1RAB9AKMT2A
SCHEMBL8171935 0.78 NAT1 (0.63) NAT1CISD1CA2EPHX1RAB9A
SCHEMBL8171937 0.78 NAT1 (0.63) NAT1CISD1CA2EPHX1RAB9A
SCHEMBL8190448 0.77 IDH1 (0.53) NAT1MMP3MMP13GSK3B
SCHEMBL8190447 0.77 IDH1 (0.53) NAT1MMP3MMP13GSK3B
SCHEMBL12892048 0.73 CRHBP (0.72) RAB9AKMT2AKDM4ENPC1HSP90AA1
SCHEMBL15347679 0.73 CRHBP (0.72) RAB9AKMT2AKDM4ENPC1HSP90AA1
SCHEMBL15347480 0.73 CRHBP (0.72) RAB9AKMT2AKDM4ENPC1HSP90AA1
SCHEMBL8179901 0.73 PTP4A3 (0.74) NAT1CISD1PTP4A3PIM1GSK3B
SCHEMBL8179904 0.73 PTP4A3 (0.74) NAT1CISD1PTP4A3PIM1GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000018748-A1 RHODANINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF METABOLIC BONE DISORDERS ROCHE DIAGNOSTICS GMBH (DE) 2000-04-06 — — WO disclosed
Send feedback